ORMP
Price
$2.12
Change
+$0.01 (+0.47%)
Updated
May 23 closing price
Capitalization
86.6M
4 days until earnings call
VIVS
Price
$1.98
Change
+$0.03 (+1.54%)
Updated
May 23 closing price
Capitalization
3.56M
Interact to see
Advertisement

ORMP vs VIVS

Header iconORMP vs VIVS Comparison
Open Charts ORMP vs VIVSBanner chart's image
Oramed Pharmaceuticals
Price$2.12
Change+$0.01 (+0.47%)
Volume$21.39K
Capitalization86.6M
VivoSim Lab
Price$1.98
Change+$0.03 (+1.54%)
Volume$32.3K
Capitalization3.56M
ORMP vs VIVS Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. VIVS commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and VIVS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (ORMP: $2.12 vs. VIVS: $1.98)
Brand notoriety: ORMP and VIVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 35% vs. VIVS: 7%
Market capitalization -- ORMP: $86.6M vs. VIVS: $3.56M
ORMP [@Biotechnology] is valued at $86.6M. VIVS’s [@Biotechnology] market capitalization is $3.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileVIVS’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • VIVS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ORMP and VIVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 3 TA indicator(s) are bullish while VIVS’s TA Score has 3 bullish TA indicator(s).

  • ORMP’s TA Score: 3 bullish, 5 bearish.
  • VIVS’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, VIVS is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а -1.40% price change this week, while VIVS (@Biotechnology) price change was -4.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.22%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

ORMP is expected to report earnings on Aug 13, 2025.

VIVS is expected to report earnings on May 22, 2025.

Industries' Descriptions

@Biotechnology (+1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($86.6M) has a higher market cap than VIVS($3.56M). VIVS YTD gains are higher at: 330.528 vs. ORMP (-12.397).
ORMPVIVSORMP / VIVS
Capitalization86.6M3.56M2,430%
EBITDA9.44MN/A-
Gain YTD-12.397330.528-4%
P/E Ratio20.91N/A-
Revenue0N/A-
Total Cash142MN/A-
Total Debt429KN/A-
FUNDAMENTALS RATINGS
ORMP vs VIVS: Fundamental Ratings
ORMP
VIVS
OUTLOOK RATING
1..100
511
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
66
Overvalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
7998
PRICE GROWTH RATING
1..100
7434
P/E GROWTH RATING
1..100
46100
SEASONALITY SCORE
1..100
18n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (60) in the Pharmaceuticals Other industry is in the same range as VIVS (66) in the Biotechnology industry. This means that ORMP’s stock grew similarly to VIVS’s over the last 12 months.

VIVS's Profit vs Risk Rating (90) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that VIVS’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (79) in the Pharmaceuticals Other industry is in the same range as VIVS (98) in the Biotechnology industry. This means that ORMP’s stock grew similarly to VIVS’s over the last 12 months.

VIVS's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for ORMP (74) in the Pharmaceuticals Other industry. This means that VIVS’s stock grew somewhat faster than ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (46) in the Pharmaceuticals Other industry is somewhat better than the same rating for VIVS (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than VIVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPVIVS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 17 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 19 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ODD69.654.84
+7.47%
ODDITY Tech Ltd
SNPX2.260.05
+2.27%
Synaptogenix
TWLO113.49-1.06
-0.93%
Twilio
MNTK1.92-0.03
-1.54%
Montauk Renewables
ARQQ25.11-0.78
-3.01%
Arqit Quantum Inc

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.47%
BTAI - ORMP
44%
Loosely correlated
N/A
INO - ORMP
44%
Loosely correlated
-2.48%
MBIO - ORMP
44%
Loosely correlated
-2.34%
VERV - ORMP
44%
Loosely correlated
+3.07%
ZNTL - ORMP
43%
Loosely correlated
-0.83%
More

VIVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIVS has been loosely correlated with GLTO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVS jumps, then GLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIVS
1D Price
Change %
VIVS100%
+1.80%
GLTO - VIVS
38%
Loosely correlated
+1.01%
ORMP - VIVS
37%
Loosely correlated
+0.47%
ACET - VIVS
27%
Poorly correlated
-3.49%
KRRO - VIVS
26%
Poorly correlated
-6.82%
SLNO - VIVS
26%
Poorly correlated
+4.90%
More